Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cardio Diagnostics Holdings (CDIO) Equity Average (2021 - 2025)

Historic Equity Average for Cardio Diagnostics Holdings (CDIO) over the last 5 years, with Q3 2025 value amounting to $8.9 million.

  • Cardio Diagnostics Holdings' Equity Average rose 16442.54% to $8.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.9 million, marking a year-over-year increase of 16442.54%. This contributed to the annual value of $6.3 million for FY2024, which is 7239.95% up from last year.
  • Cardio Diagnostics Holdings' Equity Average amounted to $8.9 million in Q3 2025, which was up 16442.54% from $10.6 million recorded in Q2 2025.
  • Over the past 5 years, Cardio Diagnostics Holdings' Equity Average peaked at $10.6 million during Q2 2025, and registered a low of $24441.0 during Q3 2021.
  • In the last 5 years, Cardio Diagnostics Holdings' Equity Average had a median value of $3.4 million in 2024 and averaged $4.8 million.
  • In the last 5 years, Cardio Diagnostics Holdings' Equity Average skyrocketed by 3933250.48% in 2022 and then tumbled by 7304.2% in 2023.
  • Cardio Diagnostics Holdings' Equity Average (Quarter) stood at $546194.0 in 2021, then surged by 1170.09% to $6.9 million in 2022, then plummeted by 62.19% to $2.6 million in 2023, then soared by 152.47% to $6.6 million in 2024, then skyrocketed by 34.98% to $8.9 million in 2025.
  • Its last three reported values are $8.9 million in Q3 2025, $10.6 million for Q2 2025, and $10.5 million during Q1 2025.